Clinical Trials Directory

Trials / Completed

CompletedNCT02794038

Accuracy & Usability Study for Soberlink Cellular Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Soberlink Healthcare LLC · Industry
Sex
All
Age
21 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study scope is to validate the accuracy and usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro.

Detailed description

The purpose of this accuracy and usability study is to validate the performance of Soberlink Cellular Device in the hands of the intended (lay) users - untrained study participants who have consumed alcohol and use the Soberlink Cellular Device to measure their blood alcohol content (BAC) in comparison to a predicate device. The purpose of this document is to define how the human factors environment impacts the actual user interface design as well as how usability engineering evaluates user interface via usability objectives and usability tests. This accuracy and usability study will be performed on Soberlink Cellular Device in order to comply with FDA's Draft Guidance for Industry and Food and Drug Administration Staff, titled: Applying Human Factors and Usability Engineering to Optimize Medical Device Design, IEC 60601-1-6 (collateral standard for usability engineering of medical electrical equipment), and IEC 62366 (application of usability engineering to medical devices).

Conditions

Interventions

TypeNameDescription
DEVICESoberlink Cellular DeviceBAC breath analyzer
DEVICEBACtrack S80 ProBAC breath analyzer

Timeline

Start date
2016-06-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-06-08
Last updated
2016-06-10

Source: ClinicalTrials.gov record NCT02794038. Inclusion in this directory is not an endorsement.